Previous 10 | Next 10 |
Gainers: Celularity CELU +10%. Purple Biotech (PPBT) +8%. BioSig Technologies (BSGM) +4%. Concert Pharmaceuticals (CNCE) +4%. Molecular Partners (MOLN) +4%. Losers: Baudax Bio BXRX -28%. Doximity DOCS -9%. Radius Health (RDUS) -7%. N...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Doximity (NYSE: DOCS ) is falling 15% after reporting results for the fiscal fourth quarter of 2022 The main concern is weak guidance for the current quarter This disappointment briefly dragged DOCS stock below i...
Retailers continued to receive attention in Wednesday's pre-market action. Lowe's (NYSE:LOW) dropped after reporting a weak revenue total for its latest quarter. Earnings news also put pressure on Doximity (DOCS). A disappointing forecast sent the stock sharply lower in pre-market action. On ...
Despite top-line and bottom-line beats with its 4Q FY22 financials yesterday, Doximity (NYSE:DOCS) has lost ~13% in the pre-market Wednesday after the online medical platform provider’s outlook for 1Q fiscal 2023 fell short of Street forecasts. Several Wall Street analys...
Baudax Bio (BXRX) -28% on launching $2M registered direct offering priced at-the-market. Target (TGT) -23% on Q1 earnings release. Doximity (DOCS) -13% on Q4 earnings release. Applied UV (AUVI) -13%. Redbox Entertainment (RDBX) -6%. DICK'S Sporting Goods (DKS) -7...
Doximity's guidance for the year ahead, somewhat as expected, is expected to slow down. The crown jewel of this investment thesis is that Doximity is a free cash flow printing machine. Doximity notes that it's only 3% penetrated into its TAM. DOCS is not expensive, with the st...
Image source: The Motley Fool. Doximity, Inc. (NYSE: DOCS) Q4 2022 Earnings Call May 17, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Doximity, Inc. (DOCS) Q4 2022 Earnings Call Transcript
Doximity, Inc. (DOCS) Q4 2022 Earnings Conference Call May 17, 2022 17:00 ET Company Participants Perry Gold - Head, Investor Relations Jeff Tangney - Co-Founder and Chief Executive Officer Nate Gross - Co-Founder and Chief Scientific Officer Anna Bryson - Chief Financial Officer Conference C...
Shares of Doximity (NYSE:DOCS) are down 18% in after-hours trading despite reporting fiscal Q4 2022 results that beat on the top and bottom lines. However, FQ3 revenue outlook of $88.6M-$89.6M is below the consensus estimate of $96.91M. Net income in the quarter surged 71% to ~...
Doximity press release (NYSE:DOCS): Q4 Non-GAAP EPS of $0.21 beats by $0.06. Revenue of $93.65M (+40.4% Y/Y) beats by $3.48M. Adjusted EBITDA of $39.4 million, versus $26.7 million, an increase of 47% year-over-year, representing adjusted EBITDA margins of 42%, versus 40%. Q1 Outlook: Re...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...